GLP-1, SGLT2 medications may lower risk of future MI and repeat stroke among stroke survivors: Study
GLP-1 receptor agonists and SGLT2 inhibitors, two classes of medications most commonly prescribed to treat Type 2 diabetes or ...
Australia: In a recent study published in Diabetes, Obesity and Metabolism, the researchers present an innovative device that ...
A new study published in the Journal of Family Medicine and Primary Care found that higher degrees of hepatic encephalopathy ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback